ArticleFrontiers in oncology2025
Multimodal imaging findings of primary renal well-differentiated neuroendocrine tumors (carcinoid): a case report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary renal well-differentiated neuroendocrine tumors (NETs) are rare. Due to their non-specific nature, the detection and monitoring of NETs remain highly challenging. Here, we report a case of a 45-year-old man who was admitted after an incidental finding of a space-occupying lesion in the kidney during a routine physical examination. The patient underwent CT and MRI multimodal imaging, followed by pathological and immunohistochemical analysis after surgery, leading to a diagnosis of well-differentiated renal NET. He was subsequently followed up for a long period. A review of the literature, in conjunction with this case, revealed that these tumors present with non-specific clinical and imaging features. Diagnosis primarily relies on pathological and immunohistochemical evaluation. Well-differentiated renal neuroendocrine tumors are associated with low malignant potential and a favorable prognosis. Surgical resection is the treatment of choice, and long-term follow-up is essential to monitor the patient's condition. By combining this case with existing literature, we aim to provide valuable insights for clinicians in the diagnosis and management of renal NETs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.